Market revenue in 2023 | USD 351.0 million |
Market revenue in 2030 | USD 357.6 million |
Growth rate | 0.3% (CAGR from 2023 to 2030) |
Largest segment | Immunoturbidimetric assay |
Fastest growing segment | Immunoturbidimetric Assay |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunoturbidimetric Assay, Chemiluminescence Immunoassay, Other Assay Types, ELISA |
Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG ADR, Danaher Corp, Quest Diagnostics Inc, Siemens Healthineers AG ADR, Abbott Laboratories, Merck KGaA, Zoetis Inc Class A, QuidelOrtho Corp, Horiba Ltd, Getein Biotech, Boditech Med, Randox, Aidian |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to c-reactive protein testing market will help companies and investors design strategic landscapes.
Immunoturbidimetric assay was the largest segment with a revenue share of 48.55% in 2023. Horizon Databook has segmented the Middle East & Africa c-reactive protein testing market based on immunoturbidimetric assay, chemiluminescence immunoassay, other assay types, elisa covering the revenue growth of each sub-segment from 2018 to 2030.
The MEA region held the lowest market share in 2020 owing to factors such as nascent stage healthcare infrastructure and low awareness about POC CRP testing devices. However, rising incidence of various chronic diseases coupled with increasing R&D investigations in the region are expected to drive the market.
Moreover, low availability of advanced diagnostic procedures, underdeveloped healthcare infrastructure, and lack of affordable treatment options make MEA an open field for investments by large manufacturers.
Furthermore, rising prevalence of non-communicable diseases in the region, increasing initiatives being undertaken by the government to reduce incidence of these diseases, and rising awareness are among factors anticipated to fuel market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa c-reactive protein testing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa c-reactive protein testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account